Clinical Trials on Patients With Febrile Neutropenia in Brazil
Total 10 results
-
Beneficência Portuguesa de São PauloMerck Sharp & Dohme LLCNot yet recruiting
-
Federal University of Minas GeraisCompletedFebrile NeutropeniaBrazil
-
AmgenCompletedChemotherapy-induced Febrile NeutropeniaFrance, Italy, Poland, Canada, Spain, Austria, Germany, Greece, Romania, Australia, Ireland
-
AmgenCompletedChemotherapy-induced Febrile NeutropeniaBelgium, Poland, Germany, Czechia, Austria, France, Greece, Romania, Bulgaria
-
PfizerCompletedFebrile NeutropeniaUnited States, Brazil, Chile, Peru, Argentina, Pakistan, Venezuela, Colombia, Finland, Mexico
-
AstraZenecaCompletedPatients With DyslipidemiaBrazil
-
Instituto do Cancer do Estado de São PauloUnknownPatients Diagnosed With Advanced Carcinoma of Uterine Cervix tBrazil
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsBrazil
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania